Company Filing History:
Years Active: 1985
Title: The Innovations of Tore Natvig
Introduction
Tore Natvig is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of inflammatory diseases. His work has led to the development of innovative drug formulations that aim to improve patient outcomes.
Latest Patents
Tore Natvig holds a patent for the use of 3,3'-azo-bis-(6-hydroxy benzoic acid) as a drug. This patent outlines a method of treating inflammatory diseases such as ulcerous colitis. The formulation includes the administration of 3,3'-azo-bis-(6-hydroxy benzoic acid) or its pharmaceutically acceptable salts. The pharmaceutical compositions are designed for oral administration and contain the compound along with acceptable carriers and/or adjuvants.
Career Highlights
Throughout his career, Tore Natvig has been associated with Pharmacia AB, where he has contributed to various research and development projects. His expertise in pharmaceutical sciences has been instrumental in advancing therapeutic options for patients suffering from chronic inflammatory conditions.
Collaborations
Tore Natvig has collaborated with several esteemed colleagues, including Karl H. Agback and Sidney C. Truelove. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pharmaceutical field.
Conclusion
Tore Natvig's contributions to the pharmaceutical industry, particularly through his patent on 3,3'-azo-bis-(6-hydroxy benzoic acid), highlight his commitment to improving treatments for inflammatory diseases. His work continues to inspire advancements in drug development and patient care.